Dravet Syndrome Market: Advancements in Rare Epilepsy Treatment Driving Growth
The Dravet Syndrome market is gaining momentum due to rising awareness of rare genetic epileptic disorders and increasing investment in targeted therapies. Innovations in precision medicine, including gene-based treatments and novel anticonvulsant drugs, are transforming patient outcomes. Additionally, supportive regulatory frameworks and growing clinical research activities are accelerating drug approvals, while improved diagnostic capabilities are enabling earlier intervention and expanding the overall market potential.